2 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Arm 3: new trials by email Literature Review of Arm 3 trials Research Report on Arm 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer Arm1, Arm 2, Arm 3 - CRC (Colorectal Cancer), BRAF | Phase 2 | Not yet recruiting | Sun Yat-sen University | 91 | 2026-11-30 | 2026-07-21 |
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19 | Phase 2 | Completed | Bateman Horne Center | 59 | 2023-10-15 | 2025-01-22 |
| Study of of URC102 to Assess the Efficacy and Safety in Gout Patients arm 0, arm 1, arm 2 - Gout | Phase 2 | Completed | JW Pharmaceutical | 171 | 2019-01-21 | 2021-03-18 |
| AGA Biocellular Stem/Stromal Hair Regenerative Study Intradermal Injection in hair loss, Platelet Rich Plasma, Adipose Derived Stem/Stromal Cells - Hair Disease | Phase 1 / Phase 2 | Withdrawn | Healeon Medical Inc | 2016-08-14 | 2025-09-12 | |
| Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study Arm1, Arm 2, Arm 3 - Oral Squamous Cell Carcinoma, Carcinoma of Buccal Mucosa | Phase 2 | Unknown | Tata Memorial Hospital | 64 | 2015-08-18 | 2022-04-28 |
| Efficacy of Macrolide Immunomodulation in Severe Sepsis. Azithromycin on admission - not enrolled in the RCT - Systemic Inflammatory Response Syndrome | Phase 2 | Terminated | VA Office of Research and Development | 100 | 2007-11-01 | 2017-04-21 |
Alopecia (1) · Colorectal Neoplasms (1) · Gout (1) · Hair Diseases (1) · Head and Neck Neoplasms (1) · Post-Acute COVID-19 Syndrome (1) · Squamous Cell Carcinoma of Head and Neck (1) · Systemic Inflammatory Response Syndrome (1) · Tongue Neoplasms (1)
Bateman Horne Center (1) · Healeon Medical Inc (1) · JW Pharmaceutical (1) · Sun Yat-sen University (1) · Tata Memorial Hospital (1) · VA Office of Research and Development (1)
United States (3) · China (1) · India (1) · South Korea (1)
Kenneth Williams, DO (1) · Lucinda Bateman, MD (1) · Marco Barusco, MD (1) · Marcos I Restrepo, MD BA MSc (1) · Ryan Welter, MD, PhD, MD,PhD (1) · Sudhir V Nair, MBBS, MS,MCh (1)
K23HL096054 (1)